02/03/22 8:00 AMNYSE : LH, TDOC Gabriela Perez Joins Big Health as Chief Commercial OfficerBig Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced the appointment of Gabriela Perez as Chief Commercial Officer. Big Health Chief Commercial Officer Gabriela Perez. Ovia Health was acquired by Labcorp in August 2021.RHEA-AIvery positive
02/02/22 4:30 PMNYSE : LH Labcorp Named to Fortune® Magazine’s 2022 ‘World’s Most Admired Companies’ List for the Fourth TimeLabcorp, a leading global life sciences company, has been named to FORTUNE ® magazine's 2022 list of the World’ s Most Admired Companies, marking its fourth appearance on the list. “Labcorp’ s global network of more than 70,000 employees capitalizes on the strength of our comprehensive capabilities to accelerate progress in areas like oncology, women’ s health...RHEA-AIneutral
01/27/22 4:15 PMNYSE : LH Labcorp Earns 100% on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ+ Workplace EqualityLabcorp, a leading global life sciences company, today announced that it received a perfect score of 100% on the Human Rights Campaign Foundation’ s 2022 Corporate Equality Index, the nation’ s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. About the Human Rights Campaign Foundation.RHEA-AIvery positive
01/26/22 9:00 AMNYSE : LH Labcorp to Offer Risk-Scoring Test for People With Advanced Liver Fibrosis Due to NASHLabcorp, a leading global life sciences company, is making this possible by offering the Enhanced Liver Fibrosis test. “Because NASH is typically addressed through lifestyle shifts such as weight loss and frequent exercise, knowing your risk of more severe damage can help you make the right changes at the right time,” said Dr. Marcia Eisenberg, chief scientific...RHEA-AIneutral
01/12/22 10:00 AMNYSE : LH clinical trialGenomOncology Pathology Workbench to Support OmniSeq INSIGHT℠, a Genomic and Immune Profiling Test That Identifies Potential Treatment and Clinical Trial Options for Solid TumorsGenomOncology announced today that GenomOncology (GO) Pathology Workbench has been selected by Labcorp's OmniSeq to support the analysis and reporting of OmniSeq INSIGHT℠, a comprehensive genomic and immune profiling test for solid tumors.OmniSeq INSIGHTRHEA-AIpositive
01/10/22 4:32 PMNYSE : LH earningsLabcorp to Announce Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022Labcorp, a leading global life sciences company, will release its financial results for the fourth quarter and full year 2021 before the market opens on Thursday, February 10, 2022. An audio replay of the conference call will be available from 1 p.m. ET on February 10, 2022, until 11:30 p.m. ET on February 24, 2022, by dialing 1-855-859-2056 within the U.S. and...RHEA-AIneutral
01/04/22 4:29 PMNYSE : LH conferencesLabcorp to Speak Virtually at the 40th Annual J.P. Morgan Healthcare ConferenceLabcorp, a leading global life sciences company, today announced that members of the executive management team will participate in a virtual fireside chat at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 11 at 4:30 p.m.. Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals,...RHEA-AIneutral
12/23/21 7:09 AMNYSE : LH Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics, a Provider of Comprehensive Liquid Biopsy and Tissue-Based Genomic Products and ServicesLabcorp, a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc., a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products. The addition of PGDx and its technology complements and accelerates Labcorp’ s existing liquid...RHEA-AIpositive
12/09/21 6:58 AMNYSE : LH Labcorp Announces Initiatives to Enhance Shareholder ValueLabcorp, a leading global life sciences company, today announced actions that its Board of Directors and management team have taken to enhance shareholder returns. As part of this program, $1 billion will be repurchased under an accelerated share repurchase plan; Implementing a new LaunchPad business process improvement initiative, targeting savings of...RHEA-AIvery positive
12/03/21 12:34 PMNYSE : LH acquisitionLabcorp Completes Acquisition of Toxikon CorporationLabcorp, a leading global life sciences company, today announced that it has closed its acquisition of Toxikon Corporation, a contract research organization delivering best-in-class nonclinical testing services. Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies,...RHEA-AIneutral